Global Artificial Saliva Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Artificial Saliva market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Artificial Saliva market."
Saliva plays an important role in chewing, swallowing, digesting, and speaking. It also helps control bacteria in your mouth, which helps prevent infection and tooth decay. Artificial saliva can relieve the symptoms of dry mouth and help you avoid health complications.
The World Health Organization data shows that oral diseases are the fourth-most expensive disease to treat in both emerging and developed economies. Oral health maintenance expenditure is a major healthcare issue directly impacting the artificial saliva market. As the artificial saliva market is consumer-based, increase in disposable income and per-capita spending are likely to drive the artificial saliva market over the course of the forecast period. A critical issue to be resolved before that is the demand-supply imbalance in the artificial saliva market that affects everybody from manufacturers to end consumers. Any supply chain deviation leads to a rise in price, reducing the ability of key players to offer products at competitive prices and boost the overall profile of the artificial saliva market.
Adult patients dominate the artificial saliva market by age group and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones. North America and Europe have a similar market share in the artificial saliva market with the former being slightly larger and on track to witness a higher CAGR.

The global Artificial Saliva market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Artificial Saliva volume and value at global level, regional level and company level. From a global perspective, this report represents overall Artificial Saliva market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    Cipla Limited
    Fresenius Kabi
    Parnell Pharmaceuticals
    Entod International
    Forward Science
    Biocosmetics Laboratories
    Icpa Health Products LTD.
    Perrigo
    Laboratorios Kin

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Oral Spray 
    Oral Solution 
    Oral Liquid 
    Gel 
    Powder

Segment by Application
    Adult 
    Paediatric